Cargando…

Ex-vivo CS1-OKT3 dual specific bivalent antibody-armed effector T cells mediate cellular immunity against multiple myeloma

Bispecific T cell engaging antibodies (bsAbs) have emerged as novel and powerful therapeutic agents for redirecting T cells towards antigen-specific tumor killing. The cell surface glycoprotein and SLAM family member, CS1, exhibits stable and high-level expression on malignant plasma cells including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awuah, Dennis, Li, Lin, Williams, Lindsay, Urak, Ryan, Kujawski, Maciej, Forman, Stephen J., Shively, John E., Wang, Xiuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682018/ https://www.ncbi.nlm.nih.gov/pubmed/38012196 http://dx.doi.org/10.1038/s41598-023-47115-7

Ejemplares similares

Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy
por: Kujawski, Maciej, et al.
Publicado: (2019)

Csak okt berben indul újra az LHC
Publicado: (2009)

Nanovesicles released by OKT3 hybridoma express fully active antibodies
por: Logozzi, Mariantonia, et al.
Publicado: (2021)

Sequential CAR T cell and targeted alpha immunotherapy in disseminated multiple myeloma
por: Awuah, Dennis, et al.
Publicado: (2023)

Spustenie najv šieho urýchľova a astíc odložili na okt ber
Publicado: (2009)

Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy
por: Urak, Ryan, et al.
Publicado: (2017)

Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients.
por: Roayaie, S, et al.
Publicado: (2000)

Dual functions of a novel effector in the plant and pathogen arms race
por: Lu, Han, et al.
Publicado: (2023)

T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4
Publicado: (1984)

Single-cell analysis by mass cytometry reveals CD19 CAR T cell spatiotemporal plasticity in patients
por: Goldberg, Lior, et al.
Publicado: (2022)

Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population
Publicado: (1981)

bMERB domains are bivalent Rab8 family effectors evolved by gene duplication
por: Rai, Amrita, et al.
Publicado: (2016)

SEROLOGIC DEMONSTRATION OF DUAL SPECIFICITY OF RABBIT BIVALENT HYBRID ANTIBODY
por: Fudenberg, H. H., et al.
Publicado: (1964)

Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor
Publicado: (1986)

Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies
Publicado: (1982)

A clinical grade cell-based artificial APT, aAPC/mOKT3, for unbiased expansion of CD3+ T lymphocytes
por: Sotov, Valentin, et al.
Publicado: (2014)

Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis
por: Boden, Elisa K, et al.
Publicado: (2019)

Anti-CS1 × Anti-CD3 Bispecific Antibody (BiAb)-Armed Anti-CD3 Activated T Cells (CS1-BATs) Kill CS1(+) Myeloma Cells and Release Type-1 Cytokines
por: Lum, Lawrence G., et al.
Publicado: (2020)

Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
por: Zah, Eugenia, et al.
Publicado: (2020)

Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens
Publicado: (1982)

An orienting response is not enough: Bivalency not infrequency causes the bivalency effect
por: Rey-Mermet, Alodie, et al.
Publicado: (2013)

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
por: Cha, Seung E., et al.
Publicado: (2021)

Regulation of miR-34b/c-targeted gene expression program by SUMOylation
por: Li, Yi-Jia, et al.
Publicado: (2018)

Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
por: Golubovskaya, Vita, et al.
Publicado: (2021)

ENaCs as Both Effectors and Regulators of MiRNAs in Lung Epithelial Development and Regeneration
por: Ding, Yan, et al.
Publicado: (2017)

Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice
por: Barrientos, Rodell C., et al.
Publicado: (2021)

MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands
por: Bird, M. F., et al.
Publicado: (2022)

Arms and ammunitions: effectors at the interface of rice and it’s pathogens and pests
por: Deb, Sohini, et al.
Publicado: (2021)

CEACAM1 regulates the IL-6 mediated fever response to LPS through the RP105 receptor in murine monocytes
por: Zhang, Zhifang, et al.
Publicado: (2019)

Binary world/bivalent logic
por: Kittler, Harald
Publicado: (2012)

CD19/BAFF-R dual targeted CAR T cells for treatment of mixed antigen-negative variants of acute lymphoblastic leukemia
por: Wang, Xiuli, et al.
Publicado: (2022)

Dual SIRT1 expression patterns strongly suggests its bivalent role in human breast cancer
por: Rifaï, Khaldoun, et al.
Publicado: (2017)

Two Novel Salmonella Bivalent Vaccines Confer Dual Protection against Two Salmonella Serovars in Mice
por: Zhao, Xinxin, et al.
Publicado: (2017)

A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3
por: Rau, Alexander, et al.
Publicado: (2021)

A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination Therapy
por: Adhikarla, Vikram, et al.
Publicado: (2021)

Learning to Centralize Dual-Arm Assembly
por: Alles, Marvin, et al.
Publicado: (2022)

APC/C(Cdh1) Enables Removal of Shugoshin-2 from the Arms of Bivalent Chromosomes by Moderating Cyclin-Dependent Kinase Activity
por: Rattani, Ahmed, et al.
Publicado: (2017)

A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer
por: Avanzino, Brian C., et al.
Publicado: (2022)

T lymphocyte-mediated suppression of myeloma function in vitro. IV. Generation of effector suppressor cells specific for myeloma idiotypes
Publicado: (1982)

High Efficiency Ex Vivo Cloning of Antigen-Specific Human Effector T Cells
por: Neller, Michelle A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5gokor09lv313d3lm9joer8upq